Organic sodium salts
- (1)
- (8)
- (7)
- (1)
- (3)
- (1)
- (1)
- (36)
- (3)
- (1)
- (2)
- (2)
- (1)
- (1)
- (6)
- (1)
- (2)
- (1)
- (28)
- (2)
- (1)
- (6)
- (1)
- (3)
- (3)
- (13)
- (3)
- (2)
- (30)
- (4)
- (1)
- (2)
- (1)
- (1)
- (5)
- (3)
- (4)
- (4)
- (3)
- (1)
- (6)
- (6)
- (2)
- (2)
- (1)
- (2)
- (3)
- (1)
- (6)
- (5)
- (3)
- (1)
- (2)
- (1)
- (3)
- (2)
- (2)
- (1)
- (1)
- (3)
- (4)
- (10)
- (11)
- (3)
- (4)
- (9)
- (8)
- (2)
- (1)
- (3)
- (3)
- (9)
- (4)
- (3)
- (5)
- (3)
- (8)
- (4)
- (6)
- (2)
- (2)
- (4)
- (2)
- (4)
- (4)
- (1)
- (2)
- (7)
- (2)
- (3)
- (3)
- (3)
- (3)
- (1)
- (16)
- (13)
- (17)
- (20)
- (1)
- (18)
- (2)
- (1)
- (4)
- (2)
- (3)
- (34)
- (2)
- (12)
- (6)
- (2)
- (11)
- (18)
- (3)
- (1)
- (14)
- (2)
- (3)
- (2)
- (2)
- (1)
- (5)
- (5)
- (1)
- (5)
- (22)
- (24)
Filtered Search Results
eMolecules 20277-69-4 | Methanesulfinic acid, sodium salt | Oakwood Chemicals | MFCD00040392 | 102.080 | CH3NaO2S | 90.000 | [Na+].CS([O-])=O | 5g | 480099553
Methanesulfinic acid, sodium salt | Oakwood Chemicals | 20277-69-4 | MFCD00040392 | 102.080 | CH3NaO2S | 90.000 | [Na+].CS([O-])=O | 5g | 480099553
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC CNQX | 115066-14-3 | MFCD00069232 | C9H4N4O4 | 100 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
CNQX (FG9065) is a potent and competitive AMPA/kainate receptor antagonist with IC50s of 0.3 μM and 1.5 μM, respectively. It functions as a competitive non-NMDA receptor antagonist and has been shown to block the expression of fear-potentiated startle in rats.
- Potent and competitive AMPA/kainate receptor antagonist
- IC50s of 0.3 μM for AMPA and 1.5 μM for kainate
- Functions as a competitive non-NMDA receptor antagonist
- Blocks expression of fear-potentiated startle in rats
- Reversibly blocks Schaffer collateral and mossy fibre EPSP in hippocampal slices
- Selectively reduces amplitude of monosynaptic component of DR-VRR in lumbar spinal segments
- Decreases cocaine responses in a dose-dependent manner in rats
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Cnqx | 115066-14-3 | C9H4N4O4 | 50 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
CNQX is a potent and competitive AMPA/kainate receptor antagonist. It has IC50s of 0.3 μM for AMPA and 1.5 μM for kainate receptors, and also acts as a competitive non-NMDA receptor antagonist.
- Potent and competitive AMPA/kainate receptor antagonist
- IC50s of 0.3 μM for AMPA and 1.5 μM for kainate receptors
- Acts as a competitive non-NMDA receptor antagonist
- Blocks the expression of fear-potentiated startle in rats
- Reversibly blocks Schaffer collateral and mossy fibre excitatory postsynaptic potential (EPSP)
- Selectively reduces the amplitude of the monosynaptic component of DR-VRR
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC CNQX disodium | 479347-85-8 | C9H2N4Na2O4 | 50 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
CNQX disodium (FG9065 disodium) is a potent and competitive antagonist of AMPA/kainate receptors, exhibiting IC50s of 0.3 μM and 1.5 μM respectively. It also functions as a competitive non-NMDA receptor antagonist and has been observed to block the expression of fear-potentiated startle in rats. This compound is primarily utilized in research focused on neurological diseases and iGluR targets.
- Potent and competitive AMPA/kainate receptor antagonist
- Competitive non-NMDA receptor antagonist
- Blocks expression of fear-potentiated startle in rats
- Used in neurological disease research
- Targets iGluR
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC CNQX disodium | 479347-85-8 | C9H2N4Na2O4 | 100 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
CNQX disodium is a potent and competitive AMPA/kainate receptor antagonist. It acts as a competitive non-NMDA receptor antagonist and has demonstrated effectiveness in blocking the expression of fear-potentiated startle in rats.
- Potent and competitive AMPA/kainate receptor antagonist.
- Competitive non-NMDA receptor antagonist.
- Blocks the expression of fear-potentiated startle in rats.
- Reversibly blocks Schaffer collateral and mossy fibre excitatory postsynaptic potential (EPSP) in hippocampal slices.
- Produces a selective and dose-dependent reduction in the amplitude of the monosynaptic component of the DR-VRR.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC NBQX | 118876-58-7 | 99.8% | 336.28 | 10 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
NBQX (FG9202) is a highly selective and competitive AMPA receptor antagonist. It possesses neuroprotective and anticonvulsant activity.
- Highly selective and competitive AMPA receptor antagonist.
- Exhibits neuroprotective activity.
- Has anticonvulsant activity.
- Decreases seizures.
- Neuroprotective in a focal ischaemia model.
- Has high affinity for AMPA and kainate binding sites.
- Shows little to no affinity for the glutamate recognition site on the NMDA receptor complex.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC CNQX disodium | 479347-85-8 | C9H2N4Na2O4 | 5 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
CNQX disodium (FG9065 disodium) is a potent and competitive AMPA/kainate receptor antagonist. It blocks the expression of fear-potentiated startle in rats and is a competitive non-NMDA receptor antagonist. It is suitable for in vitro and in vivo research.
- Potent and competitive AMPA/kainate receptor antagonist
- Blocks expression of fear-potentiated startle
- Competitive non-NMDA receptor antagonist
- Suitable for neurological disease research
- Inhibitor of ionotropic glutamate receptors
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC DNQX (FG 9041) | 2379-57-9 | C8H4N4O6 | 100 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
DNQX (FG 9041) is a quinoxaline derivative that functions as a selective, potent competitive non-NMDA glutamate receptor antagonist. It exhibits IC50 values of 0.5, 2, and 40 μM for AMPA, kainate, and NMDA receptors, respectively. This compound is known to selectively depolarize thalamic reticular nucleus (TRN) neurons.
- Selective, potent competitive non-NMDA glutamate receptor antagonist
- Exhibits IC50s of 0.5, 2, and 40 μM for AMPA, kainate, and NMDA receptors
- Selectively depolarizes thalamic reticular nucleus (TRN) neurons
- Purity of 99.67%
- Molecular weight of 252.14
- Appears as a white to off-white solid
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC NBQX (FG9202) | 118876-58-7 | C12H8N4O6S | 1 ML
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
NBQX (FG9202) is a highly selective and competitive AMPA receptor antagonist. It possesses neuroprotective and anticonvulsant activities. NBQX exhibits high affinity for AMPA and kainate binding sites, with minimal or no affinity for the glutamate recognition site on the NMDA receptor complex.
- Highly selective and competitive AMPA receptor antagonist
- Neuroprotective activity
- Anticonvulsant activity
- High affinity for AMPA and kainate binding sites
- Little to no affinity for the glutamate recognition site on the NMDA receptor complex
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC NBQX (disodium) | 479347-86-9 | MFCD00220677 | C12H6N4Na2O6S | 100 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
NBQX disodium (FG9202 disodium) is a highly selective and competitive AMPA receptor antagonist, known for its neuroprotective and anticonvulsant activities. This compound demonstrates a high affinity for AMPA and kainate binding sites, while showing minimal affinity for the glutamate recognition site on the NMDA receptor complex. Research indicates its effectiveness in protecting against focal ischaemia and reducing seizures in experimental models.
- Highly selective and competitive AMPA receptor antagonist
- Exhibits neuroprotective properties
- Shows anticonvulsant efficacy
- Possesses high affinity for AMPA and kainate binding sites
- Low affinity for NMDA receptor complex
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Benzo[f]quinoxaline-7-sulfonamide, 1,2,3,4-tetrahydro-6-nitro-2,3-dioxo-, sodium salt (1:2) | 479347-86-9 | C12H6N4Na2O6S | 25 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
NBQX disodium is a highly selective and competitive antagonist of the AMPA receptor, exhibiting neuroprotective and anticonvulsant activity. It possesses a high affinity for AMPA and kainate binding sites, with minimal affinity for the glutamate recognition site on the NMDA receptor complex.
- Highly selective and competitive AMPA receptor antagonist
- Exhibits neuroprotective activity
- Shows anticonvulsant activity
- High affinity for AMPA and kainate binding sites
- Little to no affinity for the NMDA receptor complex
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC CNQX disodium | 479347-85-8 | C9H2N4Na2O4 | 25 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
CNQX disodium is a potent and competitive antagonist for AMPA/kainate receptors, with IC50s of 0.3 μM and 1.5 μM respectively. It also acts as a competitive non-NMDA receptor antagonist and has been shown to block the expression of fear-potentiated startle in rats.
- Potent and competitive AMPA/kainate receptor antagonist
- IC50 values of 0.3 μM for AMPA and 1.5 μM for kainate receptors
- Competitive non-NMDA receptor antagonist
- Demonstrated activity in in vitro studies, including reversible blockade of Schaffer collateral and mossy fibre excitatory postsynaptic potential (EPSP)
- Demonstrated activity in in vivo studies, showing decreased cocaine responses and partial blockade of stepdown inhibitory avoidance
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
TARGETMOL CHEMICALS INC NBQX 10MG
Also available in 1 mg 5 mg 25 mg 50 mg 100 mg 200 mg 1 mL 10 mM (in DMSO) and bulk. Please contact Fisher for quotes. NBQX (FG9202) is a potent selective and competitive AMPA receptor antagonist. Neuroprotective and anticonvulsant; active in vivo. purity: 99%
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
HELLO BIO INC NBQX DISODIUM SALT 50MG
NC2198004 NBQX DISODIUM SALT 50MG
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC NBQX disodium | 479347-86-9 | C12H6N4Na2O6S | 50 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
NBQX disodium (FG9202 disodium) is a highly selective and competitive AMPA receptor antagonist. It exhibits neuroprotective and anticonvulsant activity. This product shows high affinity for AMPA and kainate binding sites, with minimal or no affinity for the glutamate recognition site on the NMDA receptor complex. It has also demonstrated neuroprotective effects in a focal ischaemia model in rats.
- Highly selective and competitive AMPA receptor antagonist
- Possesses neuroprotective activity
- Exhibits anticonvulsant activity
- High affinity for AMPA and kainate binding sites
- Minimal affinity for the glutamate recognition site on the NMDA receptor complex
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More